Non-small cell neuroendocrine carcinoma of the ovary in a BRCA2-germline mutation carrier: A case report and brief review of the literature

Genitourinary Cancer

Genomic Testing for Advanced Prostate Cancer: Ready for Prime Time?

Alexander Meisela,b

doi: 10.36000/hbT.OH.2019.02.007

Gynecologic Cancer

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

Lancet Oncol.

Pujade-Lauraine E, Ledermann JA, Selle F, Gebski V, Penson RT, Oza AM, Korach J, Huzarski T, Poveda A, Pignata S, Friedlander M, Colombo N, Harter P, Fujiwara K, Ray-Coquard I, Banerjee S, Liu J, Lowe ES, Bloomfield R, Pautier P; SOLO2/ENGOT-Ov21 investigators

doi: 10.1016/

Gynecologic Cancer

Metastatic small cell neuroendocrine carcinoma of the cervix treated with the PD-1 inhibitor, nivolumab: a case report

Gynecol Oncol Res Pract.

Paraghamian SE, Longoria TC, Eskander RN

doi: 10.1186/s40661-017-0038-9.

Hypopharyngeal squamous cell carcinoma and laryngeal neuroendocrine carcinoma colliding in the aryepiglottic fold: a case report

Tumori.

Marangoni R, Mauramati S, Bertino G, Occhini A, Benazzo M, Morbini P

doi: 10.5301/tj.5000630.

Gastrointestinal Cancer

Hepatocellular carcinoma with neuroendocrine differentiation: a case report

Exp Mol Pathol.

Lu JG, Farukhi MA, Mayeda D, French SW

doi: 10.1016/j.yexmp.2017.09.004.

Breast Cancer

High-grade poorly differentiated neuroendocrine carcinoma of the breast with low Oncotype DX Recurrence Score: A case report

Breast Dis.

Munoz-Zuluaga CA, Kotiah S, Studeman KD

doi: 10.3233/BD-170283.

Sebaceous carcinoma arising within an ovarian mature cystic teratoma: A case report with discussion of clinical management and genetic evaluation

Gynecol Oncol Rep.

Wield A, Hodeib M, Khan M, Gubernick L, Li AJ, Kandukuri S

doi: 10.1016/j.gore.2018.08.011.

Gastrointestinal Cancer

Multidisciplinary Approach to a Patient with Acinar Cell Carcinoma, a Rare Pancreatic Malignancy

healthbook Times Oncology Hematology

Palmarocchi MC, Merlo E, Cefali M, De Dosso S

doi: 10.36000/hbT.OH.2021.07.029

Lung, Respiratory and Thoracic CancerFurther Publications

Response to Osimertinib in a Patient With Non-Small Cell Lung Cancer and Two Uncommon EGFR mutations

healthbook TIMES Oncology Hematology

Astaras C, Bettini A, Betticher D.C

doi: 10.36000/hbT.OH.2020.03.01

Related content